Pretreatment Metabolic Tumor Volume As A Prognostic Factor In HPV‐associated Oropharyngeal Cancer In The Context Of AJCC 8th Edition Staging
J. Floberg, T. DeWees, R. Chin, A. Garsa, F. Dehdashti, B. Nussenbaum, P. Oppelt, D. Adkins, H. Gay, W. Thorstad
Published 2018 · Medicine
Download PDFAnalyze on Scholarcy
This study evaluates the prognostic significance of 18F‐fluorodeoxyglucose‐positron emission tomography ([F‐18]FDG‐PET)‐derived metabolic tumor volume (MTV) in human papillomavirus (HPV)‐associated oropharyngeal squamous cell carcinomas (OPSCCs) in the context of AJCC 8th edition staging.
This paper references
Predictive modeling of outcomes following definitive chemoradiotherapy for oropharyngeal cancer based on FDG-PET image characteristics.
M. Folkert (2017)
Likelihood Ratio Tests for Model Selection and Non-Nested Hypotheses
Q. Vuong (1989)
Metabolic tumour volume as a prognostic factor for oral cavity squamous cell carcinoma treated with primary surgery
H. Zhang (2014)
A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen
S. J. Smeets (2007)
Human papillomavirus and survival of patients with oropharyngeal cancer.
K. Ang (2010)
Validation that metabolic tumor volume predicts outcome in head-and-neck cancer.
C. Tang (2012)
Proposed Staging System for Patients With HPV-Related Oropharyngeal Cancer Based on Nasopharyngeal Cancer N Categories.
K. Dahlstrom (2016)
Comparison of unilateral versus bilateral intensity‐modulated radiotherapy for surgically treated squamous cell carcinoma of the palatine tonsil
R. Chin (2017)
Prognostic value of FDG‐PET volumetric parameters in patients with p16‐positive oropharyngeal squamous cell carcinoma who received curative resection followed by postoperative radiotherapy or chemoradiotherapy
K. Kim (2016)
Phase 2 Trial of De-intensified Chemoradiation Therapy for Favorable-Risk Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
B. Chera (2015)
Prognostic value of (18) F-FDG PET metabolic parameters in oropharyngeal squamous cell carcinoma
AA Garsa (2013)
Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.
S. Huang (2015)
Likelihood ratio test for model selection and nonnested hypotheses. Econometrica
QH Vuong (1989)
18F-FDG PET/CT Metabolic Tumor Volume and Total Lesion Glycolysis Predict Outcome in Oropharyngeal Squamous Cell Carcinoma
Remy Lim (2012)
Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.
B. O'Sullivan (2016)
An application of changepoint methods in studying the effect of age on survival in breast cancer
C. Contal (1999)
Tumor volume as a predictor of survival in human papillomavirus–positive oropharyngeal cancer
Kara S. Davis (2016)
HPV-Mediated (p16+) Oropharyngeal Cancer
B. O'Sullivan (2017)
Correlation between metabolic tumor volume and pathologic tumor volume in squamous cell carcinoma of the oral cavity.
J. Murphy (2011)
p16 Positive Oropharyngeal Squamous Cell Carcinoma:An Entity With a Favorable Prognosis Regardless of Tumor HPV Status
J. Lewis (2010)
Prognostic Value of Metabolic Tumor Volume Measured by 18F-FDG PET/CT in Locally Advanced Head and Neck Squamous Cell Carcinomas Treated by Surgery
Kyu-Ho Choi (2011)
Metabolic tumor volume as a prognostic imaging-based biomarker for head-and-neck cancer: pilot results from Radiation Therapy Oncology Group protocol 0522.
D. Schwartz (2015)
Reevaluation of postoperative radiation dose in the management of human papillomavirus–positive oropharyngeal cancer
R. Chin (2016)
Pathologically determined tumor volume vs pathologic T stage in the prediction of outcome after surgical treatment of oropharyngeal squamous cell carcinoma.
I. Nixon (2013)
Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation.
B. O'Sullivan (2012)
18F-FDG Metabolic Tumor Volume and Total Glycolytic Activity of Oral Cavity and Oropharyngeal Squamous Cell Cancer: Adding Value to Clinical Staging
Elizabeth H Dibble (2012)
Molecular Imaging to Plan Radiotherapy and Evaluate Its Efficacy
R. Jeraj (2015)
Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study.
I. Ciernik (2003)
FDG-PET/CT as prognostic factor and surveillance tool for postoperative radiation recurrence in locally advanced head and neck cancer
Giwon Kim (2011)
Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis.
B. O'Sullivan (2013)
Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis in Head and Neck Cancer: A Systematic Review and Meta-Analysis
K. Pak (2014)
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
R. Boellaard (2014)
Human Papillomavirus and Oropharyngeal Cancer Stage.
M. Gillison (2016)
Prognostic value of 18F-FDG PET metabolic parameters in oropharyngeal squamous cell carcinoma
Adam A. Garsa (2012)
Textural Features of Pretreatment 18F-FDG PET/CT Images: Prognostic Significance in Patients with Advanced T-Stage Oropharyngeal Squamous Cell Carcinoma
Nai-Ming Cheng (2013)
Phase 2 Trial of Deintensified Chemoradiation Therapy for Favorable-Risk Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma
BS Chera (2015)
Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.
T. La (2009)
Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity.
P. Nguyen-Tan (2014)
Human Papillomavirus and Oropharyngeal Cancer.
T. Tanaka (2018)
This paper is referenced by
Role of 18F-FDG PET-derived parameters for predicting complete response to chemoradiotherapy in squamous cell anal carcinoma
L. Filippi (2020)
PET in the Diagnosis of Head and Neck Cancer
T. Sekine (2020)
The prognostic role of 18F-fluorodeoxyglucose PET in head and neck cancer depends on HPV status.
J. M. Moan (2019)
Diagnostic Imaging in Head and Neck Cancer
H. Ojiri (2020)